No Data
No Data
COSMOS PHARMACEUTICAL CORP To Go Ex-Dividend On November 28th, 2024 With 0.286 USD Dividend Per Share
September 17th (Eastern Time) - $COSMOS PHARMACEUTICAL CORP(CSMYF.US)$ is trading ex-dividend on November 28th, 2024.Shareholders of record on November 30th, 2024 will receive 0.286 USD dividend per
COSMOS PHARMACEUTICAL CORP To Carry Out 2-for-1 Stock Split On August 29th, 2024
July 12th (Eastern Time) - $COSMOS PHARMACEUTICAL CORP(CSMYF.US)$ is about to implement a 2-for-1 stock split of shares. The shares will begin trading on a split-adjusted basis from August 29th, 2024
Kinden, Cosmos Pharmaceuticals, etc. (added) Rating
Downgrading-Bearish Code | Stock Name | Securities Company | Conventional | After Change |------|---------|---------|---------|<8515>|AIFUL | Mizuho | “Buy” | “Neutral” | Target Stock Price Change Code | Stock Name | Securities Company | Traditional | After Change |------|-|----
COSMOS PHARMACEUTICAL CORP (CSMYF.US) will release financial results on April 12
$COSMOS PHARMACEUTICAL CORP (CSMYF.US) $ will release financial results on April 12, investors stay tuned. What are the previous results? $COSMOS PHARMACEUTICAL CORP (CSMYF.US) $2024/Q2 operating income of 234.777 billion yen, net profit of 5,079 billion yen, and earnings per share of 128.18 yen. 2023/Q3 operating income of 202.286 billion yen, net profit of 4.984 billion yen, earnings per share of 125.862
Unlock the Full List